ClinicalTrials.Veeva

Menu

Clinical Evaluation of a Daily Wear Silicone Hydrogel Lens

Alcon logo

Alcon

Status

Completed

Conditions

Myopia
Refractive Errors
Hyperopia

Treatments

Device: CLEAR CARE
Device: Comfilcon A contact lenses
Device: LID015385 contact lenses

Study type

Interventional

Funder types

Industry

Identifiers

NCT04207749
CLL949-C018

Details and patient eligibility

About

The purpose of this clinical study is to assess the safety and performance of an investigational soft contact lens compared to a commercially available soft contact lens when worn in a daily wear modality with frequent replacement.

Full description

Subjects will attend 4 office visits: Screening/Baseline/Dispense; Week 1 Follow-up; Month 1 Follow-up; and Month 3 Follow-up/Exit. The total expected duration of participation for each subject is approximately 3 months.

Enrollment

249 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Key Inclusion Criteria:

  • Understand and sign an IRB/IEC approved Informed Consent form.
  • Willing and able to attend all scheduled study visits and wear the assigned study lenses as required per protocol.
  • Successful wear of frequent replacement, spherical, daily wear soft contact lenses for distance correction in both eyes during the past 3 months for a minimum of 5 days per week and 8 hours per day.
  • Manifest cylinder ≤ 0.75 diopter (D) in each eye.
  • Best spectacle corrected visual acuity 20/20 or better in each eye.
  • Other protocol-defined inclusion criteria may apply.

Key Exclusion Criteria:

  • Wearing habitual contact lenses in an extended wear modality (routinely sleeping in lenses for at least 1 night per week) over the last 3 months prior to enrollment.
  • Monovision contact lens wear.
  • Any habitual wear of Biofinity lenses.
  • Other protocol-defined exclusion criteria may apply.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

249 participants in 2 patient groups

LID015385
Experimental group
Description:
LID015385 contact lenses worn at least 5 days per week and 8 hours per day in a daily wear modality (that is, not worn while sleeping) for approximately 3 months. CLEAR CARE will be used for nightly cleaning and disinfection.
Treatment:
Device: LID015385 contact lenses
Device: CLEAR CARE
Biofinity
Active Comparator group
Description:
Comfilcon A contact lenses worn at least 5 days per week and 8 hours per day in a daily wear modality (that is, not worn while sleeping) for approximately 3 months. CLEAR CARE will be used for nightly cleaning and disinfection.
Treatment:
Device: Comfilcon A contact lenses
Device: CLEAR CARE

Trial documents
2

Trial contacts and locations

18

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems